Skip to main content
Erschienen in: Pediatric Nephrology 8/2016

14.03.2016 | Original Article

Urinary tract infection in infants caused by extended-spectrum beta-lactamase-producing Escherichia coli: comparison between urban and rural hospitals

verfasst von: Ming-Fang Cheng, Wan-Ling Chen, I-Fei Huang, Jung-Ren Chen, Yee-Hsuan Chiou, Yao-Shen Chen, Susan Shin-Jung Lee, Wan-Yu Hung, Chih-Hsin Hung, Jiun-Ling Wang

Erschienen in: Pediatric Nephrology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Community-acquired urinary tract infection (UTI) caused by extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli is an emerging problem. Compared with urban infants, rural infants may encounter different distributions of community-acquired resistant strains and various barriers to efficient management.

Methods

A retrospective survey and comparison was conducted for infants with UTI caused by ESBL-producing E. coli admitted to an urban hospital (n = 111) and a rural hospital (n = 48) in southern Taiwan from 2009 to 2012.

Results

Compared with 2009 and 2010, the total number of cases at both hospitals significantly increased in 2011 and 2012 (p < 0.001). Compared with the rural patients, the urban patients were significantly younger, and they had fewer days of fever before and after admission, fewer presentations of poor activity and poor appetite, and a lower serum creatinine level. Most of the patients had no prior history of illness, and we could not identify any significant different risk factors for acquiring ESBL-producing E. coli, such as past antimicrobial use, hospitalization, UTI, and underlying renal diseases, between the urban and rural populations.

Conclusions

The increase in community-acquired UTI in infants caused by ESBL-producing E. coli was similar between the urban and rural populations. Our preliminary data suggest that the rural–urban disparities were probably related to easy access to health care by the urban population. ESBL complicates disease management, and the increase in the prevalence of ESBL producers is a major health concern and requires further healthy carrier and environmental surveillance.
Literatur
1.
Zurück zum Zitat Calbo E, Romani V, Xercavins M, Gomez L, Vidal CG, Quintana S, Vila J, Garau J (2006) Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother 57:780–783 Calbo E, Romani V, Xercavins M, Gomez L, Vidal CG, Quintana S, Vila J, Garau J (2006) Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother 57:780–783
2.
Zurück zum Zitat Ena J, Arjona F, Martinez-Peinado C, Lopez-Perezagua Mdel M, Amador C (2006) Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Urology 68:1169–1174 Ena J, Arjona F, Martinez-Peinado C, Lopez-Perezagua Mdel M, Amador C (2006) Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Urology 68:1169–1174
3.
Zurück zum Zitat Jacoby GA, Archer GL (1991) New mechanisms of bacterial resistance to antimicrobial agents. N Engl J Med 324:601–612CrossRefPubMed Jacoby GA, Archer GL (1991) New mechanisms of bacterial resistance to antimicrobial agents. N Engl J Med 324:601–612CrossRefPubMed
4.
Zurück zum Zitat Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG (2009) Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 53:2733–2739 Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG (2009) Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 53:2733–2739
5.
Zurück zum Zitat Moor CT, Roberts SA, Simmons G, Briggs S, Morris AJ, Smith J, Heffernan H (2008) Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand. J Hosp Infect 68:355–362CrossRefPubMed Moor CT, Roberts SA, Simmons G, Briggs S, Morris AJ, Smith J, Heffernan H (2008) Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand. J Hosp Infect 68:355–362CrossRefPubMed
7.
Zurück zum Zitat Vu H, Nikaido H (1985) Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams. Antimicrob Agents Chemother 27:393–398 Vu H, Nikaido H (1985) Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams. Antimicrob Agents Chemother 27:393–398
8.
Zurück zum Zitat Cheng MF, Chen WL, Hung WY, Huang IF, Chiou YH, Chen YS, Lee SS, Hung CH, Wang JL (2015) Emergence of extended spectrum-beta-lactamase-producing Escherichia coli O25b-ST131: a major community-acquired uropathogen in infants. Pediatr Infect Dis J 34:469–475 Cheng MF, Chen WL, Hung WY, Huang IF, Chiou YH, Chen YS, Lee SS, Hung CH, Wang JL (2015) Emergence of extended spectrum-beta-lactamase-producing Escherichia coli O25b-ST131: a major community-acquired uropathogen in infants. Pediatr Infect Dis J 34:469–475
9.
Zurück zum Zitat Chung HC, Lai CH, Lin JN, Huang CK, Liang SH, Chen WF, Shih YC, Lin HH, Wang JL (2012) Bacteremia caused by extended-spectrum-beta-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob Agents Chemother 56:618–622 Chung HC, Lai CH, Lin JN, Huang CK, Liang SH, Chen WF, Shih YC, Lin HH, Wang JL (2012) Bacteremia caused by extended-spectrum-beta-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob Agents Chemother 56:618–622
10.
Zurück zum Zitat Clinical Laboratory Standards Institute (2009) Performance standards for antimicrobial susceptibility testing. 19th Informational supplement M100-S19. Clinical Laboratory Standards Institute, Wayne Clinical Laboratory Standards Institute (2009) Performance standards for antimicrobial susceptibility testing. 19th Informational supplement M100-S19. Clinical Laboratory Standards Institute, Wayne
11.
Zurück zum Zitat Chen PC, Chang LY, Lu CY, Shao PL, Tsai IJ, Tsau YK, Lee PI, Chen JM, Hsueh PR, Huang LM (2013) Drug susceptibility and treatment response of common urinary tract infection pathogens in children. J Microbiol Immunol Infect 47:478–483CrossRefPubMed Chen PC, Chang LY, Lu CY, Shao PL, Tsai IJ, Tsau YK, Lee PI, Chen JM, Hsueh PR, Huang LM (2013) Drug susceptibility and treatment response of common urinary tract infection pathogens in children. J Microbiol Immunol Infect 47:478–483CrossRefPubMed
12.
Zurück zum Zitat Roberts KB (2011) Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 128:595–610CrossRefPubMed Roberts KB (2011) Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 128:595–610CrossRefPubMed
13.
Zurück zum Zitat Finnell SM, Carroll AE, Downs SM (2011) Technical report—Diagnosis and management of an initial UTI in febrile infants and young children. Pediatrics 128:e749–e770CrossRefPubMed Finnell SM, Carroll AE, Downs SM (2011) Technical report—Diagnosis and management of an initial UTI in febrile infants and young children. Pediatrics 128:e749–e770CrossRefPubMed
14.
Zurück zum Zitat Newman TB (2011) The new American Academy of Pediatrics urinary tract infection guideline. Pediatrics 128:572–575CrossRefPubMed Newman TB (2011) The new American Academy of Pediatrics urinary tract infection guideline. Pediatrics 128:572–575CrossRefPubMed
15.
Zurück zum Zitat Roberts KB (2012) Revised AAP guideline on UTI in febrile infants and young children. Am Fam Physician 86:940–946PubMed Roberts KB (2012) Revised AAP guideline on UTI in febrile infants and young children. Am Fam Physician 86:940–946PubMed
16.
Zurück zum Zitat Tullus K (2012) What do the latest guidelines tell us about UTIs in children under 2 years of age. Pediatr Nephrol 27:509–511CrossRefPubMed Tullus K (2012) What do the latest guidelines tell us about UTIs in children under 2 years of age. Pediatr Nephrol 27:509–511CrossRefPubMed
18.
Zurück zum Zitat Mori R, Lakhanpaul M, Verrier-Jones K (2007) Diagnosis and management of urinary tract infection in children: summary of NICE guidance. BMJ 335:395–397CrossRefPubMedPubMedCentral Mori R, Lakhanpaul M, Verrier-Jones K (2007) Diagnosis and management of urinary tract infection in children: summary of NICE guidance. BMJ 335:395–397CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D (2013) Urinary tract infections caused by community-acquired extended-spectrum beta-lactamase-producing and nonproducing bacteria: a comparative study. J Pediatr 163:1417–1421CrossRefPubMed Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D (2013) Urinary tract infections caused by community-acquired extended-spectrum beta-lactamase-producing and nonproducing bacteria: a comparative study. J Pediatr 163:1417–1421CrossRefPubMed
20.
Zurück zum Zitat Topaloglu R, Er I, Dogan BG, Bilginer Y, Ozaltin F, Besbas N, Ozen S, Bakkaloglu A, Gur D (2010) Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children. Pediatr Nephrol 25:919–925CrossRefPubMed Topaloglu R, Er I, Dogan BG, Bilginer Y, Ozaltin F, Besbas N, Ozen S, Bakkaloglu A, Gur D (2010) Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children. Pediatr Nephrol 25:919–925CrossRefPubMed
21.
Zurück zum Zitat Arpin C, Dubois V, Coulange L, Andre C, Fischer I, Noury P, Grobost F, Brochet JP, Jullin J, Dutilh B, Larribet G, Lagrange I, Quentin C (2003) Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob Agents Chemother 47:3506–3514CrossRefPubMedPubMedCentral Arpin C, Dubois V, Coulange L, Andre C, Fischer I, Noury P, Grobost F, Brochet JP, Jullin J, Dutilh B, Larribet G, Lagrange I, Quentin C (2003) Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob Agents Chemother 47:3506–3514CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y (2006) Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis 42:925–934CrossRefPubMed Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y (2006) Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis 42:925–934CrossRefPubMed
23.
Zurück zum Zitat Mirelis B, Navarro F, Miro E, Mesa RJ, Coll P, Prats G (2003) Community transmission of extended-spectrum beta-lactamase. Emerg Infect Dis 9:1024–1025CrossRefPubMedPubMedCentral Mirelis B, Navarro F, Miro E, Mesa RJ, Coll P, Prats G (2003) Community transmission of extended-spectrum beta-lactamase. Emerg Infect Dis 9:1024–1025CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, Perez-Cano R, Pascual A (2004) Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 42:1089–1094 Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, Perez-Cano R, Pascual A (2004) Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 42:1089–1094
25.
Zurück zum Zitat Rogers BA, Sidjabat HE, Paterson DL (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66:1–14 Rogers BA, Sidjabat HE, Paterson DL (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66:1–14
26.
Zurück zum Zitat Valverde A, Coque TM, Sanchez-Moreno MP, Rollan A, Baquero F, Canton R (2004) Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 42:4769–4775CrossRefPubMedPubMedCentral Valverde A, Coque TM, Sanchez-Moreno MP, Rollan A, Baquero F, Canton R (2004) Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 42:4769–4775CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Rodrigues C, Shukla U, Jog S, Mehta A (2005) Extended-spectrum β-lactamase-producing flora in healthy persons. Emerg Infect Dis 11:981–982CrossRefPubMedCentral Rodrigues C, Shukla U, Jog S, Mehta A (2005) Extended-spectrum β-lactamase-producing flora in healthy persons. Emerg Infect Dis 11:981–982CrossRefPubMedCentral
28.
Zurück zum Zitat Blanc V, Leflon-Guibout V, Blanco J, Haenni M, Madec JY, Rafignon G, Bruno P, Mora A, Lopez C, Dahbi G, Dunais B, Anastay M, Branger C, Moreau R, Pradier C, Nicolas-Chanoine MH (2014) Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains. J Antimicrob Chemother 69:1231–1237 Blanc V, Leflon-Guibout V, Blanco J, Haenni M, Madec JY, Rafignon G, Bruno P, Mora A, Lopez C, Dahbi G, Dunais B, Anastay M, Branger C, Moreau R, Pradier C, Nicolas-Chanoine MH (2014) Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains. J Antimicrob Chemother 69:1231–1237
29.
Zurück zum Zitat Guimaraes B, Barreto A, Radhouani H, Figueiredo N, Gaspar E, Rodrigues J, Torres C, Igrejas G, Poeta P (2009) Genetic detection of extended-spectrum beta-lactamase-containing Escherichia coli isolates and vancomycin-resistant enterococci in fecal samples of healthy children. Microb Drug Resist 15:211–216CrossRefPubMed Guimaraes B, Barreto A, Radhouani H, Figueiredo N, Gaspar E, Rodrigues J, Torres C, Igrejas G, Poeta P (2009) Genetic detection of extended-spectrum beta-lactamase-containing Escherichia coli isolates and vancomycin-resistant enterococci in fecal samples of healthy children. Microb Drug Resist 15:211–216CrossRefPubMed
30.
Zurück zum Zitat Kothari C, Gaind R, Singh LC, Sinha A, Kumari V, Arya S, Chellani H, Saxena S, Deb M (2013) Community acquisition of beta-lactamase producing Enterobacteriaceae in neonatal gut. BMC Microbiol 13:136CrossRefPubMedPubMedCentral Kothari C, Gaind R, Singh LC, Sinha A, Kumari V, Arya S, Chellani H, Saxena S, Deb M (2013) Community acquisition of beta-lactamase producing Enterobacteriaceae in neonatal gut. BMC Microbiol 13:136CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Al-Mayahie SM (2013) Phenotypic and genotypic comparison of ESBL production by vaginal Escherichia coli isolates from pregnant and non-pregnant women. Ann Clin Microbiol Antimicrob 12:7 Al-Mayahie SM (2013) Phenotypic and genotypic comparison of ESBL production by vaginal Escherichia coli isolates from pregnant and non-pregnant women. Ann Clin Microbiol Antimicrob 12:7
32.
Zurück zum Zitat Decre D, Gachot B, Lucet JC, Arlet G, Bergogne-Berezin E, Regnier B (1998) Clinical and bacteriologic epidemiology of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit. Clin Infect Dis 27:834–844 Decre D, Gachot B, Lucet JC, Arlet G, Bergogne-Berezin E, Regnier B (1998) Clinical and bacteriologic epidemiology of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit. Clin Infect Dis 27:834–844
33.
Zurück zum Zitat Naumovski L, Quinn JP, Miyashiro D, Patel M, Bush K, Singer SB, Graves D, Palzkill T, Arvin AM (1992) Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 36:1991–1996CrossRefPubMedPubMedCentral Naumovski L, Quinn JP, Miyashiro D, Patel M, Bush K, Singer SB, Graves D, Palzkill T, Arvin AM (1992) Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 36:1991–1996CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Clinical Laboratory Standards Institute (2011) Performance standards for antimicrobial susceptibility testing. 21th Informational supplement M100-S21. Clinical Laboratory Standards Institute, Wayne Clinical Laboratory Standards Institute (2011) Performance standards for antimicrobial susceptibility testing. 21th Informational supplement M100-S21. Clinical Laboratory Standards Institute, Wayne
35.
Zurück zum Zitat Downs SM (1999) Technical report: urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics 103:e54CrossRefPubMed Downs SM (1999) Technical report: urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics 103:e54CrossRefPubMed
Metadaten
Titel
Urinary tract infection in infants caused by extended-spectrum beta-lactamase-producing Escherichia coli: comparison between urban and rural hospitals
verfasst von
Ming-Fang Cheng
Wan-Ling Chen
I-Fei Huang
Jung-Ren Chen
Yee-Hsuan Chiou
Yao-Shen Chen
Susan Shin-Jung Lee
Wan-Yu Hung
Chih-Hsin Hung
Jiun-Ling Wang
Publikationsdatum
14.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 8/2016
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-016-3338-0

Weitere Artikel der Ausgabe 8/2016

Pediatric Nephrology 8/2016 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.